Harvard Bioscience, Inc.Holliston, MA, United States (NASDAQ (GM): HBIO)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Harvard Bioscience Financial Statements

Harvard Bioscience Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Harvard Bioscience Income Statement

  2007 2006 2005
Revenue ($ mil.) 83.4 76.2 67.4
Gross Profit ($ mil.) 40.3 38.1 33.3
Operating Income ($ mil.) 9.5 8.7 7.9
Total Net Income ($ mil.) (1.4) (2.3) (31.9)
Diluted EPS (Net Income) (0.04) (0.08) (1.04)
More Harvard Bioscience financial information

Harvard Bioscience Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 23.0 22.0 24.5
Gross Profit ($ mil.) 10.8 10.3 11.6
Operating Income ($ mil.) 1.5 1.6 2.7
Total Net Income ($ mil.) (2.2) 0.7 (1.3)
Diluted EPS (Net Income) (0.07) 0.02 (0.04)
More Harvard Bioscience financial information

Harvard Bioscience Stock Quote & Chart

08/29/08 15:00:05 EST • NASDAQ • 4.58 • Decreased by -0.0700 • Decreased by -1.5054 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Harvard Bioscience Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 1.64 2.20 1.54
Price/Earnings Ratio -- 21.53 15.62
Price/Book Ratio 1.85 2.18 1.49
Price/Cash Flow Ratio 12.98 15.86 9.59
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Harvard Bioscience Financial Ratios

Harvard Bioscience Competitive Intelligence

BD Bio-Rad Labs Thermo Fisher Scientific
Annual Sales ($ mil.) 6,359.7 1,461.1 9,746.4
Employees 28,018 6,400 33,000
Market Cap ($ mil.) 21,207.5 2,257.1 25,145.0

Competitive Landscape